News
Hosted on MSN28d
FDA approves label updates for BMS’ CAR T cell therapies
B ristol Myers Squibb (BMS) has announced that the US Food and Drug Administration (FDA) has given approval to label updates for its CAR T cell therapies, Breyanzi (lisocabtagene maraleucel; liso ...
Onlymyhealth on MSN2d
Decoding Food Labels: Expert Explains What Terms Like "Lab Tested", "FSSAI Approved", or "Safe to Eat" Actually Mean
Whenever we buy food, most of us don’t read the details beyond the price and the expiry date. However, this approach is ...
Amgen (NASDAQ: NASDAQ:AMGN) announced that the U.S. Food and Drug Administration (FDA) has granted an expanded label approval for Uplizna, now approved as a treatment for immunoglobulin G4-related ...
The Food and Drug Administration (FDA) has approved an updated label for both chimeric antigen receptor (CAR) T-cell therapies, Breyanzi ® (lisocabtagene maraleucel) and Abecma ® (idecabtagene ...
Bristol Myers (BMY) receives FDA approval for label updates for Breyanzi and Abecma, that can ease access to the cancer cell therapies. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback